Ampait, Dexie O.

HRN: 26-46-37  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/08/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/08/2025
01/15/2025
INTRAVENOUS
1130 Mg
Every 6 Hours
PCAP-C
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: